arrow_back Back to App

Protect Patients from Costly Care: Medicaid and Orphan Drug Changes.

This bill aims to reverse changes that could have increased healthcare costs for individuals using Medicaid. Additionally, it restores previous rules regarding orphan drugs within the drug price negotiation program, potentially impacting the availability and pricing of medications for patients with rare diseases.
Key points
Reverses changes to Medicaid cost-sharing requirements, potentially lowering out-of-pocket expenses for patients.
Repeals changes to the exclusion for orphan drugs in the Medicare Drug Price Negotiation Program, which could lead to lower drug prices.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5094
Sponsor: Rep. Pappas, Chris [D-NH-1]
Process start date: 2025-09-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Protect Patients from Costly Care Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5094.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-02.

What are the main provisions?

Key points include:

  • Reverses changes to Medicaid cost-sharing requirements, potentially lowering out-of-pocket expenses for patients.
  • Repeals changes to the exclusion for orphan drugs in the Medicare Drug Price Negotiation Program, which could lead to lower drug prices.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Pappas, Chris [D-NH-1].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health